Abstract: In one embodiment, the object of the present invention is to provide a nephrotoxicity reducing agent for a pharmaceutical composition comprising an antisense oligomer, and a method for reducing nephrotoxicity of the pharmaceutical composition. In one embodiment, the present invention relates to a nephrotoxicity reducing agent for a pharmaceutical composition comprising an antisense oligomer, wherein the nephrotoxicity reducing agent comprises a sugar alcohol and is used in an amount such that the concentration of the sugar alcohol in the pharmaceutical composition is 1 mg/ml to 400 mg/mL.

Abstract: Cultured cells flat-cultured on a permeable sheet is stacked on other flat-cultured cells together with the permeable sheet to construct a three-dimensional tissue. The three-dimensional tissue is transplanted into a living body. Alternatively, the three-dimensional tissue is stacked up in an artificial organ device to construct a stacked-up, three-dimensional bioartificial organ module. Colony form of the cultured cell can be controlled by using a microporous sheet as the permeable sheet and controlling positions of pores in the microporous sheet to design the form of the artificial organ.